These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26560738)

  • 21. Structural insights into serotonin receptor ligands polypharmacology.
    Podlewska S; Kafel R; Lacivita E; Satała G; Kooistra AJ; Vass M; de Graaf C; Leopoldo M; Bojarski AJ; Mordalski S
    Eur J Med Chem; 2018 May; 151():797-814. PubMed ID: 29679900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of GPCR Structures on Drug Discovery.
    Congreve M; de Graaf C; Swain NA; Tate CG
    Cell; 2020 Apr; 181(1):81-91. PubMed ID: 32243800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thematic Analysis™: a chemogenomic approach to GPCR drug discovery.
    Crossley R; Macritchie JA; Slater MJ
    Curr Top Med Chem; 2011; 11(15):1925-43. PubMed ID: 21470170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Sphingolipid-binding Motif in G Protein-coupled Receptors.
    Shrivastava S; Jafurulla M; Tiwari S; Chattopadhyay A
    Adv Exp Med Biol; 2018; 1112():141-149. PubMed ID: 30637695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc Is Involved in Depression by Modulating G Protein-Coupled Receptor Heterodimerization.
    Tena-Campos M; Ramon E; Lupala CS; Pérez JJ; Koch KW; Garriga P
    Mol Neurobiol; 2016 Apr; 53(3):2003-2015. PubMed ID: 25855059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organization of higher-order oligomers of the serotonin₁(A) receptor explored utilizing homo-FRET in live cells.
    Ganguly S; Clayton AH; Chattopadhyay A
    Biophys J; 2011 Jan; 100(2):361-8. PubMed ID: 21244832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Balancing focused combinatorial libraries based on multiple GPCR ligands.
    Soltanshahi F; Mansley TE; Choi S; Clark RD
    J Comput Aided Mol Des; 2006; 20(7-8):529-38. PubMed ID: 17054016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of G Protein-Biased Ligands against 5-HT
    Lee J; Kwag R; Lee S; Kim D; Woo J; Cho Y; Kim HJ; Kim J; Jeon B; Choo H
    J Med Chem; 2021 Jun; 64(11):7453-7467. PubMed ID: 34032427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flexible scaffold-based cheminformatics approach for polypharmacological drug design.
    Chen Z; Yu J; Wang H; Xu P; Fan L; Sun F; Huang S; Zhang P; Huang H; Gu S; Zhang B; Zhou Y; Wan X; Pei G; Xu HE; Cheng J; Wang S
    Cell; 2024 Apr; 187(9):2194-2208.e22. PubMed ID: 38552625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.
    Shimada I; Ueda T; Kofuku Y; Eddy MT; Wüthrich K
    Nat Rev Drug Discov; 2019 Jan; 18(1):59-82. PubMed ID: 30410121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative Structure-Activity Relationship for High Affinity 5-HT1A Receptor Ligands Based on Norm Indexes.
    Jia Q; Cui X; Li L; Wang Q; Liu Y; Xia S; Ma P
    J Phys Chem B; 2015 Dec; 119(51):15561-7. PubMed ID: 26605982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact, determination and prediction of drug-receptor residence times for GPCRs.
    Tautermann CS
    Curr Opin Pharmacol; 2016 Oct; 30():22-26. PubMed ID: 27428776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of the structural elements in alkylated tetrahydroisoquinolines for binding to CNS receptors.
    Ofori E; Zhu XY; Etukala JR; Bricker BA; Ablordeppey SY
    Bioorg Med Chem; 2016 Nov; 24(22):5730-5740. PubMed ID: 27717652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G Protein-Coupled Receptors Incorporated into Rehydrated Diblock Copolymer Vesicles Retain Functionality.
    Gutierrez MG; Jalali-Yazdi F; Peruzzi J; Riche CT; Roberts RW; Malmstadt N
    Small; 2016 Oct; 12(38):5256-5260. PubMed ID: 27529518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane lipids in the function of serotonin and adrenergic receptors.
    Jafurulla M; Chattopadhyay A
    Curr Med Chem; 2013; 20(1):47-55. PubMed ID: 23151002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing compound libraries targeting GPCRs.
    Jacoby E
    Ernst Schering Found Symp Proc; 2006; (2):93-103. PubMed ID: 17703579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bivalent ligands for G protein-coupled receptors.
    Messer WS
    Curr Pharm Des; 2004; 10(17):2015-20. PubMed ID: 15279542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A ligand's view of target similarity: chemogenomic binding site-directed techniques for drug discovery.
    Garland SL; Gloriam DE
    Curr Top Med Chem; 2011; 11(15):1872-81. PubMed ID: 21470171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precision-engineered Peptide and Protein Analogs: Establishing a New Discovery Platform for Potent GPCR Modulators.
    Akondi KB; Paolini-Bertrand M; Hartley O
    Chimia (Aarau); 2021 Jun; 75(6):489-494. PubMed ID: 34233810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reimagining Druggability Using Chemoproteomic Platforms.
    Spradlin JN; Zhang E; Nomura DK
    Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.